Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants
AUTOR(ES)
Kleer, Celina G
FONTE
BioMed Central
RESUMO
Inflammatory breast cancer (IBC) is an aggressive form of locally advanced breast cancer (LABC) that effects approximately 5% of women with breast cancer annually in the USA. It is a clinically and pathologically distinct form of LABC that is particularly fast growing, invasive, and angiogenic. Nearly all women have lymph node involvement at the time of diagnosis, and approximately 36% have gross distant metastases. Despite recent advances in multimodality treatments, the prognosis of patients with IBC is poor, with a median disease-free survival of less than 2.5 years. Recent work on the genetic determinants that underlie the IBC phenotype has led to the identification of genes that are involved in the development and progression of this disease. This work has been aided by the establishment of primary human cell lines and animal models. These advances suggest novel targets for future interventions in the diagnosis and treatment of IBC.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=138665Documentos Relacionados
- Molecular biology of breast cancer metastasis: Genetic regulation of human breast carcinoma metastasis
- Molecular biology of breast cancer metastasis: Clinical implications of experimental studies on metastatic inefficiency
- Molecular biology of breast cancer metastasis: 'Has it spread?': disarming one of the most terrifying questions
- Molecular biology of breast cancer metastasis: The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer
- Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells